Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Encompass HealthMEX:EHC 76 3-1 Month Momentum % is 49.99% as of Sep. 15, 2026. GuruFocus rates MEX:EHC with a GF Score™ of 76/100 and a GF Value™ of MXN1,429.61 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 671 Healthcare Providers & Services companies, Encompass Health ranks better than 86.44% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-09-15), Encompass Health's 3-1 Month Momentum % is 49.99%.
The industry rank for Encompass Health's 3-1 Month Momentum % or its related term are showing as below:
MEX:EHC's 3-1 Month Momentum % is ranked better than 86.44% of 671
companies
in the Healthcare Providers & Services industry
Industry Median: 1.43
vs MEX:EHC: 49.99
Encompass Health (MEX:EHC) 3-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Encompass Health 3-1 Month Momentum % Related Terms
MEX:EHC vs DVA, UHS, ENSG: 3-1 Month Momentum % Comparison
For the Medical Care Facilities subindustry, Encompass Health's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Encompass Health 3-1 Month Momentum % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Encompass Health's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Encompass Health's 3-1 Month Momentum % falls into.
Encompass Health (MEX:EHC) 3-1 Month Momentum % Calculation
3-1 Month Momentum % is calculated as following:
3-1 Month Momentum %
=
( Price 1-month ago
/
Price 3-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Encompass Health (MEX:EHC) has a 3-1 Month Momentum % of 49.99% as of Sep. 15, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Encompass Health and its competitors. According to the industry distribution chart, Encompass Health ranks #91 out of 671 companies in the Healthcare Providers & Services industry, placing it in the top 13.6%.
Is Encompass Health's 3-1 Month Momentum % too high?
Encompass Health's current 3-1 Month Momentum % is 49.99%. The Healthcare Providers & Services industry median 3-1 Month Momentum % is 1.43. Encompass Health's value of 49.99% is 3395.8% above this industry median. Based on the distribution chart, Encompass Health ranks #91 out of 671 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Encompass Health has a GF Score™ of 76/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Encompass Health's 3-1 Month Momentum % compare to DVA and UHS?
According to the Healthcare Providers & Services industry distribution chart, Encompass Health ranks #91 out of 671 companies for 3-1 Month Momentum %. This places Encompass Health in the top 14% of its industry — outperforming the majority of peers. The industry median 3-1 Month Momentum % is 1.43. Encompass Health's value of 49.99% is 3395.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Healthcare Providers & Services company?
The median 3-1 Month Momentum % among Healthcare Providers & Services companies is 1.43, based on 671 companies in the industry. Companies in the top quartile (top 25%) have a 3-1 Month Momentum % significantly above this median, while those in the bottom quartile fall well below. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Encompass Health's current 3-1 Month Momentum % of 49.99% is 3395.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Encompass Health and its competitors. For the Healthcare Providers & Services industry, the median 3-1 Month Momentum % is 1.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Encompass Health's current 3-1 Month Momentum % is 49.99%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Encompass Health stock overvalued right now?
Based on GuruFocus' analysis, Encompass Health (MEX:EHC) is currently considered Significantly Overvalued. The stock's GF Value™ is MXN1,429.61, compared to a current price of MXN2,068.00 — trading 44.7% above its estimated fair value. The current 3-1 Month Momentum % is 49.99% and 3395.8% above the Healthcare Providers & Services industry median of 1.43. Encompass Health's overall GF Score™ is 76/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Encompass Health (MEX:EHC), the current 3-1 Month Momentum % is 49.99% as of Sep. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Encompass Health (MEX:EHC) Overvalued in 2026?
Based on GuruFocus' analysis, Encompass Health stock appears to be overvalued.
The current stock price of MXN2,068.00 is trading 44.7% above its estimated GF Value™ of MXN1,429.61.
GuruFocus considers Encompass Health to be Significantly Overvalued.
Key valuation signals for MEX:EHC:
3-1 Month Momentum %: 49.99%
GF Value™: MXN1,429.61 vs. price of MXN2,068.00 (44.7% above fair value)
Industry Position: 3395.8% above the Healthcare Providers & Services median (#91 of 671)
No single metric tells the full story. See the MEX:EHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals, which is the company's sole segment. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. The company's inpatient rehabilitation hospitals provide a higher level of rehabilitative care to patients who are recovering from conditions such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
76GF Score
Get the complete analysis for MEX:EHC
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:EHC has been successfully added to your 
